ライフサイエンスコーパス: total hip replacement

1 sk for minor bleeding in patients undergoing total hip replacement.

2 grafting (CABG), carotid endarterectomy, and total hip replacement.

3 ere concordant for hip OA, as ascertained by total hip replacement.

4 lulare, septic wrist, bacteremia, and septic total hip replacement.

5 s had a total knee replacement and 825 had a total hip replacement.

6 eral elective surgical treatments, including total hip replacement.

7 For total hip replacement, 10-year implant survival rate was

8 resection ($63117 vs $21325; P < .001), and total hip replacement ($41354 vs $19028; P < .001).

9 that strongly associate with osteoarthritis total hip replacement: a missense variant, c.1141G>C (p.

10 als performing coronary artery bypass graft, total hip replacement, abdominal aortic aneurysm repair,

11 identified 63 158 patients who had undergone total hip replacement and 54 276 who had total knee repl

12 Among patients who had total knee or total hip replacement and received 4 to 10 days of posto

13 nce challenges the increasing trend for more total hip replacements and total knee replacements to be

14 replacement, 214 patients who had undergone total hip replacement, and 520 controls from the UK.

15 y, other comorbidity, admission FIM ratings, total hip replacement, and time to followup.

16 performed a genome-wide association study of total hip replacements, based on variants identified thr

17 ted with increased risk of readmission after total hip replacement: being older than 71 years (OR, 1.

18 suggests that the satisfaction of demand for total hip replacement, given agreed criteria for surgery

19 d rates of CABG, carotid endarterectomy, and total hip replacement in 158 hospital-referral regions (

20 imate the population requirement for primary total hip replacement in England.

21 dance on wisdom tooth extraction and primary total hip replacement in the UK National Health Service.

22 Total hip replacement is a commonly performed orthopedic

23 Death within 90 days after total hip replacement is rare but might be avoidable dep

24 07647), pulmonary resection (n = 91758), and total hip replacement (n = 307399) between 2009 and 2012

25 ity, comorbidity, admission FIM ratings, and total hip replacement, OA was associated with a longer r

26 quiring revision surgery in patients who had total hip replacement or total knee replacement over the

27 Practice Research Datalink who had undergone total hip replacement or total knee replacement.

28 In the 1960s, total hip replacement revolutionised management of elder

29 The Readmission After Total Hip Replacement Risk Scale was developed to predic

30 cation models, such as the Readmission After Total Hip Replacement Risk Scale, can identify high-risk

31 ey were used to create the Readmission After Total Hip Replacement Risk Scale, which was applied to t

32 rom a registry of patients who had undergone total hip replacement surgery over an 8-year period at a

33 The requirement for total hip replacement surgery was estimated on the basis

34 ndergone a primary or revision total knee or total hip replacement surgery.

35 if another family member also had undergone total hip replacement surgery.

36 For total hip replacement there was no significant change in

37 ABG) (218940 patients at 1056 hospitals), or total hip replacement (THR) (231774 patients at 1831 hos

38 Mortality and complication rates after total hip replacement (THR) are inversely associated wit

39 Total hip replacement (THR) is extremely common.

40 Implant survival after conventional total hip replacement (THR) is often poor in younger pat

41 Total hip replacement (THR) is successful in treating hi

42 ompared with patients undergoing an elective total hip replacement (THR) operation.

43 es the risk for venous thromboembolism after total hip replacement (THR) or total knee replacement (T

44 nd-stage hip osteoarthritis (OA) who undergo total hip replacement (THR) preferentially require subse

45 hyte score, decrease in MJS of > or =0.5 mm, total hip replacement (THR), and increase in lower extre

46 e rates in patients with hip OA undergoing a total hip replacement (THR), as compared with disease-fr

47 rates varied widely for patients undergoing total hip replacement (THR), colectomy, and pancreaticod

48 s, the progression of the disease required a total hip replacement (THR).

49 nter tenderness, hip pain or tenderness, and total hip replacement (THR).

50 h) and predictive validity (association with total hip replacement [THR] and signs and symptoms a mea

51 en concordant for primary OA (ascertained by total hip replacement [THR] or total knee replacement),

52 knee replacements (TKRs), and 537 women with total hip replacements (THRs) from the Nottingham case-c

53 proportion of male patients ranged from 37% (total hip replacement) to 77% (abdominal aortic aneurysm

54 endarterectomy, reduction of femur fracture, total hip replacement, total knee replacement, partial c

55 es who underwent future targeted procedures (total hip replacement, total knee replacements) or nonta

56 nical characteristics of patients undergoing total hip replacement were abstracted.

57 en concordant for primary OA (ascertained by total hip replacement), were genotyped for 36 microsatel

58 ervices dictate that further developments in total hip replacement will be governed by their cost-eff